Vera Therapeutics, Inc. · NASDAQ:VERA

T. Rowe Price Associates Inc reported a 7.70% stake in Vera Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

T. Rowe Price Associates Inc reported a 7.70% stake in Vera Therapeutics, Inc., 5,461,988 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
7.70%
Shares
5,461,988
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.7.70%5,461,988

Source

View original at SEC

Related